Correlation Between Europlasma and Neovacs SA
Can any of the company-specific risk be diversified away by investing in both Europlasma and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Europlasma and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Europlasma SA and Neovacs SA, you can compare the effects of market volatilities on Europlasma and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Europlasma with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Europlasma and Neovacs SA.
Diversification Opportunities for Europlasma and Neovacs SA
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Europlasma and Neovacs is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Europlasma SA and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Europlasma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Europlasma SA are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Europlasma i.e., Europlasma and Neovacs SA go up and down completely randomly.
Pair Corralation between Europlasma and Neovacs SA
Assuming the 90 days trading horizon Europlasma SA is expected to under-perform the Neovacs SA. But the stock apears to be less risky and, when comparing its historical volatility, Europlasma SA is 4.82 times less risky than Neovacs SA. The stock trades about -0.82 of its potential returns per unit of risk. The Neovacs SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 0.03 in Neovacs SA on August 24, 2024 and sell it today you would lose (0.01) from holding Neovacs SA or give up 33.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Europlasma SA vs. Neovacs SA
Performance |
| Timeline |
| Europlasma SA |
| Neovacs SA |
Europlasma and Neovacs SA Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Europlasma and Neovacs SA
The main advantage of trading using opposite Europlasma and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Europlasma position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.The idea behind Europlasma SA and Neovacs SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Neovacs SA vs. Europlasma SA | Neovacs SA vs. Biophytis SA | Neovacs SA vs. Cellectis | Neovacs SA vs. Innate Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |